Each 30mL vial contains sterile water with 0.9% benzyl alcohol as a preservative, providing a stable, multi-use reconstitution medium trusted by research professionals
Monitoring pending requests, calling payers when decisions are overdue, and escalating urgent cases
IV (weekly): 250 mg/week or 500 mg/week , depending on the infusion length/volume
Fully independent peer-reviewed replication of Dihexas specific potency claims (including the widely cited 7 orders of magnitude more potent than BDNF figure from the original work) is limited
"Therefore, the referenced complaint represents an MDR reportable event as defined in 21 CFR 803.3(o)," the agency
Note: Individuals with a history of peptide hypersensitivity should consult a physician before use